Testing effectiveness (Phase 2)Study completedNCT04527575
What this trial is testing
Study of the Safety, Reactogenicity and Immunogenicity of "EpiVacCorona" Vaccine for the Prevention of COVID-19
Who this might be right for
Covid19
Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" 100